comparemela.com

Page 5 - Fierce Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AstraZeneca-Daiichi s Dato-DXd didn t prove OS benefit in phase 3

Daiichi Sankyo and ADC partner AstraZeneca have already filed Dato-DXd with the FDA, but the latest readout casts a shadow over the application.

Takeda, amid restructuring campaign, plots 641 layoffs at two Massachusetts sites

A recently announced $900 million restructuring drive is already making waves at Takeda, wi

CRISPR Tx finds CMO in Sanofi leader—Chutes & Ladders

CRISPR Tx finds CMO in Sanofi leader—Chutes & Ladders
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

Merus cancer bispecific lives up to investors expectations

Merus cancer bispecific lives up to investors expectations
fiercebiotech.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercebiotech.com Daily Mail and Mail on Sunday newspapers.

GSK sets diversity targets, partners with DEI firm for education

GSK is doubling down on clinical trial diversity effort, starting with defined enrollment targets and training trial staff on DEI in healthcare.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.